First Financial Equity Corporation’s AbbVie ABBV Stock Holding History

First Financial Equity Corporation’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.43M	Buy	+21,869	New	+$1.37M	0.25%	108

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

First Financial Equity Corporation's ABBV Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in AbbVie (ABBV) in Q1 2017: 21,869 shares worth $1.43M. The stake represents 0.25% of the portfolio and ranks #108 among its holdings.

1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

First Financial Equity Corporation held 21,869 shares of AbbVie worth $1.43M as of Q1 2017.
AbbVie was a new First Financial Equity Corporation position in Q1 2017.
AbbVie made up 0.25% of First Financial Equity Corporation's portfolio in Q1 2017, its #108 holding.
1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.